Good Life Advisors LLC Trims Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Good Life Advisors LLC lessened its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 39.9% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 928 shares of the healthcare conglomerate's stock after selling 617 shares during the quarter. Good Life Advisors LLC's holdings in UnitedHealth Group were worth $470,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. State Street Corp boosted its stake in shares of UnitedHealth Group by 1.3% during the 3rd quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate's stock worth $26,626,387,000 after acquiring an additional 563,554 shares in the last quarter. Geode Capital Management LLC boosted its position in UnitedHealth Group by 1.6% during the third quarter. Geode Capital Management LLC now owns 19,636,704 shares of the healthcare conglomerate's stock worth $11,440,133,000 after purchasing an additional 318,039 shares in the last quarter. Franklin Resources Inc. increased its position in shares of UnitedHealth Group by 2.5% in the third quarter. Franklin Resources Inc. now owns 8,061,916 shares of the healthcare conglomerate's stock valued at $4,884,019,000 after buying an additional 193,800 shares in the last quarter. International Assets Investment Management LLC lifted its position in shares of UnitedHealth Group by 78,814.4% during the 3rd quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate's stock valued at $3,096,896,000 after buying an additional 5,290,025 shares in the last quarter. Finally, Fisher Asset Management LLC increased its holdings in UnitedHealth Group by 3.5% in the 3rd quarter. Fisher Asset Management LLC now owns 3,197,167 shares of the healthcare conglomerate's stock worth $1,869,320,000 after acquiring an additional 107,097 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

UNH has been the subject of a number of research reports. Oppenheimer boosted their target price on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an "outperform" rating in a research note on Friday, December 6th. Wells Fargo & Company reduced their target price on UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating for the company in a report on Tuesday, January 28th. Piper Sandler dropped their price target on UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating for the company in a research report on Thursday, January 2nd. Cantor Fitzgerald reaffirmed an "overweight" rating and set a $700.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. Finally, Barclays decreased their price target on shares of UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating on the stock in a research note on Friday, January 17th. One investment analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Buy" and an average target price of $629.32.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the stock in a transaction that occurred on Friday, January 17th. The stock was purchased at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now directly owns 4,500 shares of the company's stock, valued at $2,302,065. This trade represents a 28.57 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 0.33% of the company's stock.

UnitedHealth Group Trading Down 7.3 %

UnitedHealth Group stock traded down $36.84 during midday trading on Friday, reaching $465.58. 19,847,353 shares of the stock traded hands, compared to its average volume of 4,805,500. The firm has a market cap of $428.46 billion, a PE ratio of 30.04, a price-to-earnings-growth ratio of 1.40 and a beta of 0.61. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The company has a 50-day simple moving average of $520.37 and a two-hundred day simple moving average of $561.26.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts' consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. During the same period in the previous year, the company posted $5.83 earnings per share. The business's revenue for the quarter was up 6.8% on a year-over-year basis. Research analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.